The Ratios of CD8+ T Cells to CD4+CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Ratios of CD8+ T Cells to CD4+CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer

Published:2013-11-14 Issue:11 Volume:8 Page:e80063
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Preston Claudia C.,Maurer Matthew J.,Oberg Ann L.,Visscher Daniel W.,Kalli Kimberly R.,Hartmann Lynn C.,Goode Ellen L.,Knutson Keith L.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference44 articles.

1. Current management strategies for ovarian cancer;GD Aletti;Mayo Clin Proc,2007

2. Cancer of the ovary;SA Cannistra;N Engl J Med,2004

3. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study;RF Ozols;J Clin Oncol,2003

4. Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel;P Hoskins;J Natl Cancer Inst,2010

5. Current academic clinical trials in ovarian cancer: Gynecologic Cancer InterGroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009;EL Trimble;Int J Gynecol Cancer,2010

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preoperative Immune Cell Dysregulation Accompanies Ovarian Cancer Patients into the Postoperative Period;International Journal of Molecular Sciences;2024-06-28

2. Dendritic Cells in Shaping Anti-Tumor T Cell Response;Cancers;2024-06-13

3. Virtual clinical trials via a QSP immuno-oncology model to simulate the response to a conditionally activated PD-L1 targeting antibody in NSCLC;Journal of Pharmacokinetics and Pharmacodynamics;2024-06-10

4. Tumor-Infiltrating T Cells in Skin Basal Cell Carcinomas and Squamous Cell Carcinomas: Global Th1 Preponderance with Th17 Enrichment—A Cross-Sectional Study;Cells;2024-06-03

5. Blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responses;British Journal of Cancer;2024-04-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3